Skip to content

The use of ashwagandha tail uttarabasti for the treatment of prostatomegaly

THE ASSESSMENT OF EFFICACY OF ASHWAGANDHA TAIL UTTARABASTI IN THE MANAGEMENT OF VATASHTILA W.S.R.TO BPH - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068552
Enrollment
81
Registered
2024-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Sponsors

Dr Suyesha Baburao Jadhav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 50to 70 with no significant medical history Patient having classical signs and symptoms of mootraghata/BPH like increase frequency urgency hesitancy weak stream of urine scanty micturation

Exclusion criteria

Exclusion criteria: Patients of malignancy congenital deformities of urogenital tract or any abdomino pelvic pathology other than BPH Systemic disease like uncontrolled hypertension and diabetes mellitus will be excluded

Design outcomes

Primary

MeasureTime frame
To assess the effect of ashwagandha tail uttarabasti in terms of pacifying the symptoms like frequency urgency hesitancy intermittency prostate sizeTimepoint: For 2 weeks at 1 week of interval Follow up will be done on 0 7 14 21 and 30 th day

Secondary

MeasureTime frame
To get relief from prostate symptoms like frequency of urination weak stream urgency intermittentancy nocturia Straining The effect of Ashwagandha tail for the treatment of vatashtila To relief the symptoms of BPHTimepoint: For 2 weeks at 1 week of interval Follow up will be done on 0 7 14 21 & 30 th day 1 year will over the course of study

Countries

India

Contacts

Public ContactDr Suyesha Baburao Jadhav

Dr G D Pol foundation ymt ayurvedic medical college hospital and pg institute

dnyanesh7373@gmail.com7795250154

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026